Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FLUDEOXYGLUCOSE F 18 INJECTION USP safely and effectively. See full prescribing information for FLUDEOXYGLUCOSE F 18 INJECTION USP. FLUDEOXYGLUCOSE F 18 INJECTION USP for intravenous use Initial U.S. Approval: 2005
Medication labelWhy this: Advisory · dailymed-prescription
Fludeoxyglucose F 18 Injection USP is indicated for positron emission tomography (PET) imaging in the following settings: For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. For the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures.
- generic_name
- fludeoxyglucose f 18
- product_names
- Fludeoxyglucose F 18
- ndc
- 75913-647, 75913-647-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en